mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.006 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.006 |
mRNA |
Methotrexate |
GDSC1000 |
pan-cancer |
AAC |
-0.081 |
0.006 |
mRNA |
AKT inhibitor VIII |
GDSC1000 |
pan-cancer |
AAC |
0.095 |
0.006 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.007 |
mRNA |
BHG712 |
GDSC1000 |
pan-cancer |
AAC |
0.081 |
0.007 |
mRNA |
AZ628 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.007 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.14 |
0.007 |
mRNA |
LE-135 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.008 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.008 |